[1] | Madrid-Silva AM, Defilippi-Caffri C, Landskron-Ramos G, et al. The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile. Rev Gastroenterol Mex. 2013 Oct-Dec; 78(4): 203-10. doi: 10.1016/j.rgmx.2013.07.004. |
[2] | Rajilić-Stojanović M, Jonkers DM, Salonen A, et al. Intestinal Microbiota and Diet in IBS: Causes, Consequences, or Epiphenomena? The American Journal of Gastroenterology. 2015; 110(2): 278-287. doi: 10.1038/ajg.2014.427. |
[3] | Sayuk GS, Gyawali CP. Irritable bowel syndrome: modern concepts and management options. Am J Med. 2015 Aug; 128(8): 817-27. doi: 10.1016/j.amjmed.2015.01.036. |
[4] | Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015 Mar 3; 313(9): 949-58. doi: 10.1001/jama.2015.0954. |
[5] | Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7): 712-721.e4. |
[6] | Makker J, Chilimuri S, Bella JN. Genetic epidemiology of irritable bowel syndrome. World Journal of Gastroenterology: WJG. 2015; 21(40): 11353-11361. doi: 10.3748/wjg.v21.i40.11353. |
[7] | Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3(11): 1057-65. |
[8] | Chandar AK. Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. International Journal of General Medicine. 2017; 10: 385-393. doi:10.2147/IJGM.S126581. |
[9] | El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology: WJG 2015; 21(25): 7621-7636. doi: 10.3748/wjg.v21.i25.7621. |
[10] | D'Amato M. enes and functional GI disorders: from casual to causal relationship. Neurogastroenterol Motil. 2013 Aug; 25(8): 638-49. |
[11] | Camilleri M. Genetics of Human Gastrointestinal Sensation. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2013; 25(6): 458-466. doi:10.1111/nmo.12132. |
[12] | Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther. 2007; 26: 979–986. |
[13] | Jarrett ME, Kohen R, Cain KC, Burr RL, Poppe A, Navaja GP, Heitkemper MM. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs. 2007; 9:161–169. |
[14] | Kohen R, Jarrett ME, Cain KC, Jun SE, Navaja GP, Symonds S, Heitkemper MM. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci. 2009; 54:2663–2670. |
[15] | De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut. 2004 Oct; 53(10): 1520-35. |
[16] | Saha L. Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine. World Journal of Gastroenterology. WJG 2014; 20(22): 6759-6773. doi: 10.3748/wjg.v20.i22.6759. |
[17] | Aguas M, Garrigues V, Bastida G, et al. Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD). J Crohns Colitis. 2011 Jun; 5(3): 227-33. doi: 10.1016/j.crohns.2011.01.008. |
[18] | Longstreth GF, et al. In: ROME III: The Functional Gastrointestinal Disorders. Drossman DA, et al., editors. Degnon Associates; 2006. pp. 487–556. |
[19] | Grzesiak M, Beszłej JA, Mulak A, et al. The lifetime prevalence of anxiety disorders among patients with irritable bowel syndrome. Adv Clin Exp Med. 2014 Nov-Dec; 23(6): 987-92. doi: 10.17219/acem/37356. |
[20] | Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012 Jul; 107(7): 991-1000. doi: 10.1038/ajg.2012.131. |
[21] | World Gastroenterology Organization. Irritable bowel syndrome: a global perspective. World Gastroenterology Organisation Global Guideline 2009. Available from: http://www.jupiterpharma.in/journalpdf/IBS WORLD GASTRO.pdf. |
[22] | Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012 Jul; 10(7): 712-721. e4. doi: 10.1016/j.cgh.2012.02.029. |
[23] | Alhazmi AH. Irritable bowel syndrome in secondary school male students in AlJouf Province, north of Saudi Arabia. J Pak Med Assoc. 2011 Nov; 61(11): 1111-5. |
[24] | Devanarayana NM, Rajindrajith S, Pathmeswaran A, Abegunasekara C, Gunawardena NK, Benninga MA. Epidemiology of irritable bowel syndrome in children and adolescents in Asia. J Pediatr Gastroenterol Nutr. 2015 Jun; 60(6): 792-8. doi: 10.1097/MPG.0000000000000714. |
[25] | Ibrahim NKR, Battarjee WF, Almehmadi SA. Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah. The Libyan Journal of Medicine. 2013; 8: 10.3402/ljm.v8i0.21287. doi:10.3402/ljm.v8i0.21287. |
[26] | Ibrahim NK. A systematic review of the prevalence and risk factors of irritable bowel syndrome among medical students. Turk J Gastroenterol. 2016 Jan; 27(1): 10-6. doi: 10.5152/tjg.2015.150333. |
[27] | Ibrahim NK, Al-Bloushy RI, Sait SH, Al-Azhary HW, Al Bar NH, Mirdad GA. Irritable bowel syndrome among nurses working in King Abdulaziz University Hospital, Jeddah, Saudi Arabia. The Libyan Journal of Medicine. 2016; 11:10.3402/ljm.v11.30866. doi: 10.3402/ljm.v11.30866. |
[28] | AlKhalifah MI, Al-Aql AM, Al-Mutairi MS, et al. Prevalence of irritable bowel syndrome among Qassim school teachers, and its impact on their performance and life duties. Saudi Medical Journal. 2016; 37(7): 817. doi: 10.15537/smj.2016.7.15043. |
[29] | Alaqeel MK, Alowaimer NA, Alonezan AF, Almegbel NY, Alaujan FY. Prevalence of Irritable Bowel Syndrome and its Association with Anxiety among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Riyadh. Pakistan Journal of Medical Sciences. 2017; 33(1): 33-36. doi: 10.12669/pjms.331.12572. |
[30] | Zubaidi AM, Al-Saud NH, Al-Qahtani XA, et al. Bowel function and its associated variables in Saudi adults. A population based study. Saudi Med J. 2012 Jun; 33(6): 627-33. |
[31] | Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 Dec; 123(6): 2108-31. |
[32] | Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002 Aug 17; 360(9332): 555-64. |
[33] | Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012 Dec; 36(11-12): 1009-31. |
[34] | Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009 May; 136(6):1979-88. |
[35] | Ishihara S, Tada Y, Fukuba N, et al. Pathogenesis of irritable bowel syndrome--review regarding associated infection and immune activation. Digestion. 2013; 87(3):204-11. |
[36] | Spiller RC. Effects of serotonin on intestinal secretion and motility. Curr Opin Gastroenterol. 2001 Mar; 17(2):99-103. |
[37] | De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut. 2004 Oct; 53(10):1520-35. |
[38] | Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2006 Aug; 55(8):1095-103. |
[39] | Degen L, Matzinger D, Merz M, et al. Aliment Pharmacol Ther. 2001 Nov; 15(11): 1745-51. |
[40] | Mayer EA, Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother. 2003 Nov; 4(11): 2089-98. |
[41] | Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1998 Sep; 12(9): 849-55. |
[42] | Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011 Jun; 9(6): 461-9; quiz e59. |
[43] | Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: the role of other psychosocial variables. Digestion. 2005; 72(2-3):86-96. |
[44] | Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut. 2000 Dec; 47(6):861-9. |
[45] | Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology. 1994 Jul; 107(1): 271-93. |
[46] | Ibrahim NKR, Battarjee WF, Almehmadi SA. Prevalence and predictors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah. The Libyan Journal of Medicine 2013; 8:10.3402/ljm.v8i0.21287. doi: 10.3402/ljm.v8i0.21287. |
[47] | Mohamed AS, Khan BA. A More Positive Diagnosis of Irritable Bowel Syndrome in Saudi Patients. 1999; 19(5): 459-461. DOI: 10.5144/0256-4947.1999.459. |
[48] | Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormones. World Journal of Gastroenterology: WJG 2014; 20(22): 6725-6743. doi: 10.3748/wjg.v20.i22.6725. |
[49] | Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med 2002; 5: 37–45. |
[50] | McCarberg BH. Clinical overview of fibromyalgia. Am J Ther 2012; 19: 357–368. |
[51] | Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001;17 Suppl 1:s4–12. |
[52] | Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenterol 2006; 101: S644–S653. |
[53] | Walker EA, Gelfand AN, Gelfand MD, Green C, Katon WJ. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol 1996; 17: 39–46. |
[54] | Dinos S, Khoshaba B, Ashby D, White PD, Nazroo J, Wessely S, Bhui KS. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol 2009; 38: 1554–1570. |
[55] | Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry 2007; 19: 247–255. |
[56] | Unruh AM. Gender variations in clinical pain experience. Pain 1996; 65:123–167. |
[57] | Mulak A, Taché Y, Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World Journal of Gastroenterology: WJG. 2014; 20(10): 2433-2448. doi: 10.3748/wjg.v20.i10.2433. |
[58] | Thakur ER, Quigley BM, El-Serag HB, Gudleski GD, Lackner JM, Representing the IBS Outcome Study Research Group. Medical Comorbidity and Distress in Patients with Irritable Bowel Syndrome: The Moderating Role of Age. Journal of psychosomatic research 2016; 88:48-53. doi: 10.1016/j.jpsychores.2016.07.006. |
[59] | Zhu JZ, Yan TL, Yu CH, Wan XY, Wang YM, Li YM. Is national socioeconomic status related to prevalence of irritable bowel syndrome? J Gastroenterol Hepatol 2014 Aug; 29(8): 1595-602. doi: 10.1111/jgh.12609. |
[60] | Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004 Aug; 99(8): 1572-8. |
[61] | Saito YA, Petersen GM, Larson JJ, et al. Familial Aggregation of Irritable Bowel Syndrome: A Family Case –Control Study. The American journal of gastroenterology 2010; 105(4): 833-841. doi:10.1038/ajg.2010.116. |
[62] | Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998; 93:1311–7. |
[63] | Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001; 121:799–804. |
[64] | Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol. 2005; 100: 1340–4. |
[65] | Bengtson MB, Ronning T, Vatn MH, et al. Irritable bowel syndrome in twins: genes and environment. Gut. 2006; 55: 1754–9. |
[66] | Lembo A, Zaman M, Jones M, et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007; 25: 1343–50. |